Clinical Implications of the NICE 2015 Criteria for Gestational Diabetes Mellitus

Background: In response to concerns that the International Association of Diabetes in Pregnancy Study Group (IADPSG) criteria labeled too many women with gestational diabetes mellitus (GDM) without evidence of clinical or economic benefit, NICE recommended a change in diagnostic criteria in 2015. Aim: To compare diabetes associated maternal and neonatal complications in pregnancies complicated by GDM diagnosed using IADPSG criteria only, to those with GDM diagnosed using both IADPSG and NICE 2015 criteria. GDM screening was risk factor based. Methods: This was a secondary analysis of a trial of women with GDM diagnosed by the IADPSG criteria (fasting blood glucose (BG) ≥ 5.1 mmol/L, 1 h ≥ 10.0 mmol/L and 2 h ≥ 8.5 mmol/L). Outcomes were compared for two groups: NICE + IADPSG defined as those with GDM diagnosed by both the NICE 2015 and IADPSG criteria (fasting BG ≥ 5.6 mmol/L, 2 h ≥ 8.5 mmol/L); and IADPSG-ONLY (fasting BG 5.1 mmol/L to 5.5 mmol/L, and/or 1-hour ≥10.0 mmol/L, and 2 h ≥ 8.5 mmol/L). We were not able to obtain data for women with a 2-h value between BG 7.8–8.4 mmol/L (i.e., NICE-ONLY; NICE 2015 positive and IADPSG negative). All women were treated for GDM using targets of fasting BG < 5.3 mmol/L and 1-h post prandial BG < 7.8 mmol/L respectively. Results: Of 159 women, 65 (40.9%) were NICE + IADPSG and 94 (59.1%) IADPSG-ONLY. Hypoglycaemic medication use was similar in both groups: 52.3% NICE + IADPSG, 46.8% IADPSG-ONLY, OR 1.0 (0.5–1.9). The IADPSG-ONLY group delivered later than the NICE + IADPSG group; 39.0 weeks (sd 1.4) compared to 38.2 weeks (sd 2.5), p value 0.02. Fewer caesarean sections occurred in IADPSG-ONLY group 30.9% vs. 52.3%, OR 0.4 (0.2–0.9). Birthweight, large for gestational age, and other neonatal complications were not significantly different between groups. Conclusions: Gestational diabetes-associated perinatal complications were similar in both groups. The IADPSG criteria detect women with evidence of ongoing hyperglycaemia who may benefit from treatment during pregnancy.

[1]  Caroline A Crowther,et al.  Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. , 2005, The New England journal of medicine.

[2]  H. Murphy,et al.  Diagnosis of gestational diabetes mellitus: falling through the net , 2015, Diabetologia.

[3]  Sigridur Sia Jonsdottir,et al.  Hyperglycemia and Adverse Pregnancy Outcomes , 2009 .

[4]  Isabelle Runkle,et al.  Introduction of IADPSG Criteria for the Screening and Diagnosis of Gestational Diabetes Mellitus Results in Improved Pregnancy Outcomes at a Lower Cost in a Large Cohort of Pregnant Women: The St. Carlos Gestational Diabetes Study , 2014, Diabetes Care.

[5]  Jonathan Webber,et al.  Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period (NG3) , 2015 .

[6]  L. Tarassenko,et al.  Trial protocol to compare the efficacy of a smartphone-based blood glucose management system with standard clinic care in the gestational diabetic population , 2016, BMJ Open.

[7]  Bengt Persson,et al.  Hyperglycemia and Adverse Pregnancy Outcomes , 2009 .

[8]  Maicon Falavigna,et al.  Gestational diabetes and pregnancy outcomes - a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria , 2012, BMC Pregnancy and Childbirth.

[9]  J. Bernstein,et al.  Lost opportunities to prevent early onset type 2 diabetes mellitus after a pregnancy complicated by gestational diabetes , 2016, BMJ Open Diabetes Research and Care.

[10]  N. Melamed,et al.  The impact of adoption of the international association of diabetes in pregnancy study group criteria for the screening and diagnosis of gestational diabetes. , 2015, American journal of obstetrics and gynecology.

[11]  P. Damm,et al.  Global cost-effectiveness of GDM screening and management: current knowledge and future needs. , 2015, Best practice & research. Clinical obstetrics & gynaecology.

[12]  Letícia S. Weinert,et al.  International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy , 2010, Diabetes Care.

[13]  F. Mcauliffe,et al.  Prediction and prevention of Gestational Diabetes: an update of recent literature. , 2016, European journal of obstetrics, gynecology, and reproductive biology.

[14]  J. Stockman.  Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes , 2007 .

[15]  A. Hingorani,et al.  Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis , 2009, The Lancet.

[16]  C. Crowther,et al.  Women with gestational diabetes mellitus in the ACHOIS trial: Risk factors for shoulder dystocia , 2007, The Australian & New Zealand journal of obstetrics & gynaecology.

[17]  Lei A. Clifton,et al.  Comparing the Efficacy of a Mobile Phone-Based Blood Glucose Management System With Standard Clinic Care in Women With Gestational Diabetes: Randomized Controlled Trial , 2018, JMIR mHealth and uHealth.

[18]  R. Devlieger,et al.  IADPSG and WHO 2013 Gestational Diabetes Mellitus Criteria Identify Obese Women With Marked Insulin Resistance in Early Pregnancy , 2016, Diabetes Care.

[19]  D. McIntyre,et al.  Suggested consensus for the diagnosis of gestational diabetes , 2014 .

[20]  Dwight J Rouse,et al.  A multicenter, randomized trial of treatment for mild gestational diabetes. , 2009, The New England journal of medicine.